Picture of CervoMed logo

CRVO — CervoMed News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

CervoMed Inc expected to post a loss of 29 cents a share - Earnings Preview

* CervoMed Inc  CRVO.OQ   CRVO.O  is expected to report
resultson
March 22 (estimated) for the period ending December 31 2023
    * The Boston Massachusetts-based  company is expected to
report
revenue of $2 million, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for CervoMed Inc is for a
loss
of 29 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CervoMed
Inc is
$50.00​, above​ its last closing price of $24.44. ​​​

This summary was machine generated March 20 at 20:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on CervoMed

See all news